Brian Weinshenker

Professor

University of Virginia

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Brian Weinshenker is a Professor at the University of Virginia in the United States. His research primarily focuses on neuromyelitis optica spectrum disorders, with recent publications exploring topics such as the efficacy and safety of monoclonal antibodies and the imaging features of critical demyelinating lesions. He has contributed significantly to understanding the clinical and demographic characteristics of neuromyelitis optica, assisting in the advancement of treatment options for this condition.

Articles (24)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (7)

Kazuo Fujihara

Professor/MD

Tohoku Daigaku

JAPAN

View details

Jeffrey Bennett

Professor

University of Denver

UNITED STATES

View details

Jing Sun

Professor

Griffith University Griffith Health

AUSTRALIA

View details

Nathan Schilaty

Assistant Professor

University of South Florida

UNITED STATES

View details

Alessandro Dinoto

Fondazione IRCCS Istituto Neurologico Carlo Besta

ITALY

View details

Filippo Savoldi

Istituto Neurologico Carlo Besta

ITALY

View details

Elia Sechi

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Brian Weinshenker

Research Interests

Explore related searches

Contact this professor

About

Articles (24)

Long-Term Efficacy and Safety of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disorder From the SAkuraMoon Open-Label Extension Study

Cerebellar Involvement in Attacks of Aquaporin-4-IgG Positive Neuromyelitis Optica Spectrum Disorder

Emerging Role of Targeted Monoclonal Antibodies in Neuromyelitis Optica Spectrum Disorders

Relapsing tumefactive demyelination: time to recognize a distinct demyelinating condition?

Sex ratio and age of onset in AQP4 antibody-associated NMOSD: a review and meta-analysis

Sex ratio and age of onset in AQP4 antibody-associated NMOSD: a review and meta-analysis

MR Imaging Features of Critical Spinal Demyelinating Lesions Associated with Progressive Motor Impairment

McArdle sign and neck flexion-induced change in central motor conduction in multiple sclerosis

Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trial

Hemicord White Matter Enhancement and the Croissant Sign in Cervical Spondylotic Myelopathy

Alterations in Aquaporin-4-IgG Serostatus in 986 Patients: A Laboratory-Based Longitudinal Analysis

Association of Specific "Critical" Demyelinating Lesions and Motor Impairment in Progressive Multiple Sclerosis: A Prospective Study

Attack adjudication in neuromyelitis optica spectrum disorder: Substantiation of criteria by magnetic resonance imaging and biomarkers in N-MOmentum

Frequency of demyelinating disease activity following immune checkpoint inhibitor cancer immunotherapy

Inebilizumab Reduces Attack Risk Independent of Low Affinity IgG Fc Region Receptor IIIA Gene Polymorphisms in Neuromyelitis Optica Spectrum Disorder

Neuromotor control associates with muscle weakness observed with McArdle sign of multiple sclerosis

Frequency of Asymptomatic Optic Nerve Enhancement in a Large Retrospective Cohort of Patients With Aquaporin-4+ NMOSD

Vessel Wall Enhancement in Unilateral Primary Angiitis of the Central Nervous System

CSF Kappa Free Light Chains: Cutoff Validation for Diagnosing Multiple Sclerosis

Hope for patients with neuromyelitis optica spectrum disorders — from mechanisms to trials

Utility of MRI Enhancement Pattern in Myelopathies With Longitudinally Extensive T2 Lesions

CNS Demyelinating Attacks Requiring Ventilatory Support With Myelin Oligodendrocyte Glycoprotein or Aquaporin-4 Antibodies

Comparison of MRI Lesion Evolution in Different Central Nervous System Demyelinating Disorders

Disability Outcomes in the N-MOmentum Trial of Inebilizumab in Neuromyelitis Optica Spectrum Disorder

Collaborators (7)

Kazuo Fujihara

Jeffrey Bennett

Jing Sun

Nathan Schilaty

Alessandro Dinoto

Filippo Savoldi

Elia Sechi

Make your next move.